Medicare Enrolled
Dr. Mikell Jarratt, M.D.
Pulmonary Disease · Gastonia, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jarratt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jarratt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jarratt
Dr. Mikell Jarratt is a pulmonary disease specialist in Gastonia, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Jarratt performed 1,929 Medicare services across 945 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jarratt received a total of $45,593 from 67 pharmaceutical and/or device companies across 882 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jarratt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in NC
$45,593 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,929
Medicare services
Top 14% in NC for pulmonary disease
945
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
671 | $61 | $177 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
441 | $62 | $176 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
301 | $58 | $176 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
113 | $129 | $495 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
101 | $23 | $95 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $88 | $248 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
60 | $38 | $98 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
46 | $19 | $106 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
42 | $31 | $122 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
42 | $41 | $159 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $122 | $385 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $76 | $218 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$45,593
Total received (2018-2024)
Avg $6,513/year across 7 years
Top 8% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
882
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31,251 (68.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,342 (31.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,164
2023
$2,261
2022
$2,267
2021
$9,233
2020
$11,733
2019
$15,776
2018
$2,158
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$302
AstraZeneca Pharmaceuticals LP
$193
GENZYME CORPORATION
$162
Novo Nordisk Inc
$155
Bayer Healthcare Pharmaceuticals Inc.
$136
Actelion Pharmaceuticals US, Inc.
$133
Boehringer Ingelheim Pharmaceuticals, Inc.
$130
Lilly USA, LLC
$108
Mylan Specialty L.P.
$97
Regeneron Healthcare Solutions, Inc.
$96
ABBVIE INC.
$83
Avadel CNS Pharmaceuticals, LLC
$79
Insmed, Inc.
$67
Electromed, Inc.
$66
Mallinckrodt Hospital Products Inc.
$56
PFIZER INC.
$48
Radius Health, Inc.
$46
Janssen Pharmaceuticals, Inc
$36
Amgen Inc.
$30
Merck Sharp & Dohme LLC
$28
Inspire Medical Systems, Inc.
$26
SHIELD THERAPEUTICS INC
$23
Novartis Pharmaceuticals Corporation
$21
Verity Pharmaceuticals Inc.
$17
Dexcom, Inc.
$15
MEDICOMP INC
$13
Top 3 companies account for 30.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$30,959
AstraZeneca Pharmaceuticals LP
$1,749
ViiV Healthcare Company
$1,600
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,304
Merck Sharp & Dohme Corporation
$874
Novo Nordisk Inc
$842
Janssen Pharmaceuticals, Inc
$696
Mylan Specialty L.P.
$605
Lilly USA, LLC
$587
Regeneron Healthcare Solutions, Inc.
$512
Insmed, Inc.
$460
Actelion Pharmaceuticals US, Inc.
$427
Amgen Inc.
$406
GENZYME CORPORATION
$401
Radius Health, Inc.
$287
ABBVIE INC.
$277
Sunovion Pharmaceuticals Inc.
$274
Bayer Healthcare Pharmaceuticals Inc.
$265
Mallinckrodt Hospital Products Inc.
$193
Electromed, Inc.
$190
Philips Electronics North America Corporation
$180
Circassia Pharmaceuticals Inc
$159
PFIZER INC.
$145
Grifols USA, LLC
$135
Bayer HealthCare Pharmaceuticals Inc.
$133
Teva Pharmaceuticals USA, Inc.
$126
Harmony Biosciences LLC
$122
Genentech USA, Inc.
$111
Paratek Pharmaceuticals, Inc.
$90
Novartis Pharmaceuticals Corporation
$88
Merck Sharp & Dohme LLC
$87
Inogen, Inc.
$83
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$83
Avadel CNS Pharmaceuticals, LLC
$79
SANOFI-AVENTIS U.S. LLC
$78
Amarin Pharma Inc.
$74
AbbVie Inc.
$62
Shield Therapeutics Inc
$62
Nabriva Therapeutics, plc
$62
Takeda Pharmaceuticals U.S.A., Inc.
$57
Eisai Inc.
$51
Abbott Laboratories
$47
Masimo Corporation
$46
Biohaven Pharmaceutical Holding Company Ltd.
$42
Inspire Medical Systems, Inc.
$41
Resmed Corp
$39
CeQur Corporation
$37
Pulmonx Corporation
$34
Biohaven Pharmaceuticals, Inc.
$34
JAZZ PHARMACEUTICALS INC.
$32
Baxter Healthcare
$29
SHIELD THERAPEUTICS INC
$23
E.R. Squibb & Sons, L.L.C.
$21
Astellas Pharma US Inc
$17
Verity Pharmaceuticals Inc.
$17
Mallinckrodt Enterprises LLC
$17
Shire North American Group Inc
$15
Dexcom, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$14
Fisher & Paykel Healthcare Inc
$13
Mallinckrodt LLC
$13
OptiNose US, Inc.
$13
ADVANCED RESPIRATORY, INC
$13
MEDICOMP INC
$13
Daiichi Sankyo Inc.
$12
Advanced Respiratory, Inc
$12
Tactile Systems Technology Inc
$11
Top 3 companies account for 75.2% of all-time payments
Associated products mentioned in payments ›
(8746) Vent Connectivity · (8874) inCourage · (8876) Vest Therapy Und · ACCRUFER · ACTHAR · AIR 11 · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · AirDuo Digihaler · Arikayce · BASAGLAR · BEVESPI AEROSPHERE · BEXSERO · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CAPVAXIVE · CHANTIX · CHARTIS CATHETER · CINQAIR · CeQur Simplicity · DUAKLIR PRESSAIR · DUPIXENT · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · FORTEO · FREESTYLE LIBRE 3 · Flexitouch Plus · FreeStyle Libre 2 · GLASSIA · Hillrom - Life 2000 Ventilation System · IMFINZI · INJECTAFER · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · INVOKANA · InogenOne · JANUVIA · JARDIANCE · Kerendia · LONHALA MAGNAIR · LUMRYZ · Levemir · Livalo · MK-7264 · MOUNJARO · NUCALA · NURTEC ODT · NUZYRA · OFEV · OPSUMIT · Otezla · Ozempic · PNEUMOVAX 23 · PREVNAR 20 · Perforomist · Prolastin-C Liquid · Prolia · Pulmonx Endobronchial Valve EBV · QGE031 · QULIPTA · QVAR · Repatha · Rybelsus · SEEBRI · SET and rainbow SET · SHINGRIX · SMARTVEST · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · TELEPATCH CARDIAC MONITOR · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · The VitalCough System · Tlando · Tresiba · Trilogy 100 · Tymlos · UBRELVY · UPTRAVI · UTIBRON · Utibron · VESICARE · VRAYLAR · Vascepa · Victoza · WAKIX · Wakix · Wegovy · XARELTO · XIFAXAN · XOLAIR · XYWAV · Xenleta · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for pulmonary disease in NC.
Geographic Context
Pulmonary diseases within 10 mi
28
Per 100K population
12.1
County median income
$65,472
Nearest hospital
CAROMONT REGIONAL MEDICAL CENTER
5.1 mi
5.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jarratt is a clinical cardiology specialist, with above-average Medicare volume (top 14% in NC), with speaking/promotional industry engagement in the top 8% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jarratt experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Jarratt performed 671 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jarratt receive payments from pharmaceutical companies?
Yes. Dr. Jarratt received a total of $45,593 from 67 companies across 882 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jarratt's costs compare to other pulmonary diseases in Gastonia?
Dr. Jarratt's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jarratt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Gastonia
Browse pulmonary diseases in Gastonia ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NC
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NC
Which NC pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology